Hydroxychloroquine is available as the brand-name drug Plaquenil. Generic drugs usually cost less than the brand-name version. Hydroxychloroquine may be used as part of a combination therapy. Moa of plaquenil Hydroxychloroquine for lupus side effects Retinal pigment epithelial mottling of macula plaquenil Plaquenil is the brand name for the prescription drug hydroxychloroquine. It's used to treat and prevent malaria infection, and to reduce symptoms and progression of autoimmune diseases such as lupus, rheumatoid arthritis, and others. Hydroxychloroquine, sulphasalazine, methotrexate chronic phase drugs The medical care of patients with chronic Chikungunya must take place in referral units with professionals qualified to assist these patients. After the 2014–2015 outbreak of chikungunya virus in the US Virgin Islands, we compared the prevalence of persistent arthralgia among case-patients and controls. Prevalence was higher in case-patients than controls 6 and 12 months after disease onset. Hydroxychloroquine is used to treat lupus erythematosus and rheumatoid arthritis. It isn’t fully understood how this drug works to treat lupus erythematosus or rheumatoid arthritis. That means you may need to take it with other drugs. It treats malaria by killing the parasites that cause the disease. Hydroxychloroquine in chikungunya Chikungunya arthritis, Pharmacologic management of pain in patients with Chikungunya a guideline Calcium autophagy chloroquinePlaquenil saliva According to the American College of Rheumatology, hydroxychloroquine Plaquenil, is a “disease-modifying anti-rheumatic drug DMARD,” meaning that it helps reduce the pain and swelling that come with arthritis. It can also reduce the incidence of joint damage. RA and Hydroxychloroquine How Effective is it for Rheumatoid.. Persistent Arthralgia Associated with Chikungunya Virus Outbreak, US.. A Case of Chikungunya Arthritis. Mar 03, 2017 The study was not designed to address treatment, but data from previous studies suggest that combination disease-modifying antirheumatic drug therapy may be more effective than hydroxychloroquine monotherapy for chronic joint pain post Chikungunya, the researchers noted. The researchers had no financial conflicts to disclose. A clinical trial conducted during the chikungunya outbreak in 2006 in Réunion Island showed that oral chloroquine treatment did not improve the course of the acute disease De Lamballerie et al. 2008 and that chronic arthralgia on day 300 post-illness was more frequent in treated patients than in the control group Roques et al. 2018. Hydroxychloroquine is a disease-modifying anti-rheumatic drug DMARD. It regulates the activity of the immune system, which may be overactive in some conditions. Hydroxychloroquine can modify the underlying disease process, rather than simply treating the symptoms.